Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Stephen Lamond News

Stephen Lamond News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Stephen Lamond. Real-time updates on events, politics, business and more.

Peak Bio, Inc. Announces Filing of Provisional Patent Applications for PH-1, a Novel and Specific Immunomodulatory ADC payload platform targeting RNA splicing

September 19, 2023
Pleasanton, CA, Sept. 19, 2023 -- Peak Bio, Inc. , is a clinical-stage biopharmaceutical company focused on developing and commercializing the next-generation of innovative therapeutics that aim...
United States Stephen Lamond Trademark Office Exchange Commission Peak Bio Inc United States Patent
Source: marketscreener.com

Peak Bio, Inc. Announces Amendment and Continued Access to Equity Line of up to $100 Million USD via an Accelerated Common Stock Purchase Transaction with White Lion Capital

August 24, 2023
Pleasanton, CA, Aug. 24, 2023 -- Peak Bio, Inc. , is a clinical-stage biopharmaceutical company focused on developing and commercializing the next-generation of innovative therapeutics that aim to...
Stephen Lamond Exchange Commission White Lion Capital Peak Bio Inc Common Stock Purchase Agreement White Lion
Source: marketscreener.com

Peak Bio, Inc. Presents Preclinical Data Highlighting Potential of Differentiated Trop2 PH1 (Novel Payload) ADC in Poster at 2023 AACR Annual Meeting

August 23, 2023
Pleasanton, CA, Aug. 23, 2023 -- Peak Bio, Inc. , is a clinical-stage biopharmaceutical company focused on developing the next-generation of therapeutics to treat oncology and inflammatory...
Stephen Lamond Exchange Commission Globenewswire Inc Peak Bio Inc Peak Bio Molecular Therapeutics
Source: marketscreener.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Peak Bio, Inc. Announces Closing of up to $100 Million Common Stock Purchase Transaction with White Lion Capital

November 4, 2022
04.11.2022 - Peak Bio, Inc. (Peak Bio or the Company) (NASDAQ: PKBO), a clinical-stage biopharmaceutical company focused on developing the next-generation of therapeutics to treat oncology and inflammatory diseases, today announced that it has entered into a ... Seite 1
Stephen Lamond Peak Bio Inc White Lion Capital Peak Bio Common Stock Purchase Agreement
Source: wallstreet-online.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science